Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients.
Lehmkuhl HB, Mai D, Dandel M, Knosalla C, Hiemann NE, Grauhan O, Huebler M, Pasic M, Weng Y, Meyer R, Rothenburger M, Hummel M, Hetzer R.
Lehmkuhl HB, et al. Among authors: hummel m.
J Heart Lung Transplant. 2007 Jul;26(7):700-4. doi: 10.1016/j.healun.2007.02.008. Epub 2007 Apr 6.
J Heart Lung Transplant. 2007.
PMID: 17613400
Clinical Trial.